FOLLICULAR GRADE 3 LYMPHOMA

Clinical trials for FOLLICULAR GRADE 3 LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR GRADE 3 LYMPHOMA trials appear

Sign up with your email to follow new studies for FOLLICULAR GRADE 3 LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

An open-label, phase i trial, with an expansion cohort: macrophage conditioning to synergize with CAR-T in high-risk lymphoma (MAC-SHIFT)

Not yet recruiting

Axatilimab + CAR-T in High-Risk Lymphoma

Matched conditions: FOLLICULAR GRADE 3 LYMPHOMA

Phase: PHASE1 • Sponsor: Northside Hospital, Inc.

Last updated Jun 17, 2026 21:19 UTC

FOLLICULAR GRADE 3 LYMPHOMA

Get alerted when new FOLLICULAR GRADE 3 LYMPHOMA trials appear

An open-label, phase i trial, with an expansion cohort: macrophage conditioning to synergize with CAR-T in high-risk lymphoma (MAC-SHIFT)